| Year |
Citation |
Score |
| 2018 |
Del'Guidice T, Lepetit-Stoffaes JP, Bordeleau LJ, Roberge J, Théberge V, Lauvaux C, Barbeau X, Trottier J, Dave V, Roy DC, Gaillet B, Garnier A, Guay D. Membrane permeabilizing amphiphilic peptide delivers recombinant transcription factor and CRISPR-Cas9/Cpf1 ribonucleoproteins in hard-to-modify cells. Plos One. 13: e0195558. PMID 29617431 DOI: 10.1371/Journal.Pone.0195558 |
0.331 |
|
| 2016 |
Juneau PM, Garnier A, Duchesne C. Monitoring of adherent live cells morphology using the Undecimated Wavelet Transform Multivariate Image Analysis (UWT-MIA). Biotechnology and Bioengineering. PMID 27477880 DOI: 10.1002/Bit.26064 |
0.327 |
|
| 2016 |
Del'Guidice T, Lepetit-Stoffaes J, Roberge J, Bordeleau L, Harvey M, Garnier A, Guay D. 603. Feldan Shuttle - Advanced Protein Delivery Technology for Cell Therapy Molecular Therapy. 24: S239. DOI: 10.1016/S1525-0016(16)33411-6 |
0.357 |
|
| 2016 |
Ouellet DL, Rousseau J, Cherif K, Gérard C, Gilbert R, Garnier A, Gaillet B, Beauséjour C, Tremblay JP. 321. Deletion of Mutated GAA Repeats from the Intron 1 of the Frataxin Gene Using the CRISPR System Restores the Protein Expression in a Friedreich Ataxia Model Molecular Therapy. 24: S129. DOI: 10.1016/S1525-0016(16)33130-6 |
0.302 |
|
| 2016 |
Parent VA, Tremblay JP, Garnier A. Rational design of a serum-free culture medium for the growth of human myoblasts destined to cell therapy The Canadian Journal of Chemical Engineering. 94: 1855-1862. DOI: 10.1002/Cjce.22586 |
0.325 |
|
| 2013 |
Segura MM, Mangion M, Gaillet B, Garnier A. New developments in lentiviral vector design, production and purification. Expert Opinion On Biological Therapy. 13: 987-1011. PMID 23590247 DOI: 10.1517/14712598.2013.779249 |
0.313 |
|
| 2012 |
Michaud FT, Havugimana PC, Duchesne C, Sanschagrin F, Bernier A, Lévesque RC, Garnier A. Cell culture tracking by multivariate analysis of raw LCMS data. Applied Biochemistry and Biotechnology. 167: 474-88. PMID 22562494 DOI: 10.1007/S12010-012-9661-4 |
0.344 |
|
| 2012 |
Leysi-Derilou Y, Duchesne C, Garnier A, Pineault N. Single-cell level analysis of megakaryocyte growth and development. Differentiation; Research in Biological Diversity. 83: 200-9. PMID 22387343 DOI: 10.1016/J.Diff.2011.12.003 |
0.361 |
|
| 2012 |
Garnier A, Voyer R, Tom R, Perret S, Jardin B, Kamen A. Dissolved carbon dioxide accumulation in a large scale and high density production of TGFβ receptor with baculovirus infected Sf-9 cells. Cytotechnology. 22: 53-63. PMID 22358915 DOI: 10.1007/Bf00353924 |
0.332 |
|
| 2012 |
Robert A, Cortin V, Garnier A, Pineault N. Megakaryocyte and platelet production from human cord blood stem cells. Methods in Molecular Biology (Clifton, N.J.). 788: 219-47. PMID 22130711 DOI: 10.1007/978-1-61779-307-3_16 |
0.313 |
|
| 2011 |
Segura MM, Kamen AA, Garnier A. Overview of current scalable methods for purification of viral vectors. Methods in Molecular Biology (Clifton, N.J.). 737: 89-116. PMID 21590394 DOI: 10.1007/978-1-61779-095-9_4 |
0.323 |
|
| 2010 |
Leysi-Derilou Y, Robert A, Duchesne C, Garnier A, Boyer L, Pineault N. Polyploid megakaryocytes can complete cytokinesis. Cell Cycle (Georgetown, Tex.). 9: 2589-99. PMID 20647776 DOI: 10.4161/Cc.9.13.12078 |
0.337 |
|
| 2010 |
Segura MM, Garnier A, Durocher Y, Ansorge S, Kamen A. New protocol for lentiviral vector mass production. Methods in Molecular Biology (Clifton, N.J.). 614: 39-52. PMID 20225034 DOI: 10.1007/978-1-60761-533-0_2 |
0.363 |
|
| 2010 |
Gaillet B, Gilbert R, Broussau S, Pilotte A, Malenfant F, Mullick A, Garnier A, Massie B. High-level recombinant protein production in CHO cells using lentiviral vectors and the cumate gene-switch. Biotechnology and Bioengineering. 106: 203-15. PMID 20178120 DOI: 10.1002/Bit.22698 |
0.395 |
|
| 2009 |
Caron AW, Nicolas C, Gaillet B, Ba I, Pinard M, Garnier A, Massie B, Gilbert R. Fluorescent labeling in semi-solid medium for selection of mammalian cells secreting high-levels of recombinant proteins. Bmc Biotechnology. 9: 42. PMID 19432976 DOI: 10.1186/1472-6750-9-42 |
0.339 |
|
| 2009 |
Cortin V, Pineault N, Garnier A. Ex vivo megakaryocyte expansion and platelet production from human cord blood stem cells. Methods in Molecular Biology (Clifton, N.J.). 482: 109-26. PMID 19089352 DOI: 10.1007/978-1-59745-060-7_7 |
0.329 |
|
| 2008 |
Segura MM, Kamen A, Garnier A. Purification of retrovirus particles using heparin affinity chromatography. Methods in Molecular Biology (Clifton, N.J.). 434: 1-11. PMID 18470635 DOI: 10.1007/978-1-60327-248-3_1 |
0.336 |
|
| 2008 |
Segura MM, Garnier A, Di Falco MR, Whissell G, Meneses-Acosta A, Arcand N, Kamen A. Identification of host proteins associated with retroviral vector particles by proteomic analysis of highly purified vector preparations. Journal of Virology. 82: 1107-17. PMID 18032515 DOI: 10.1128/Jvi.01909-07 |
0.33 |
|
| 2007 |
Gilbert PA, Kamen A, Bernier A, Garnier A. A simple macroscopic model for the diffusion and adsorption kinetics of r-adenovirus. Biotechnology and Bioengineering. 98: 239-51. PMID 17597100 DOI: 10.1002/Bit.21340 |
0.544 |
|
| 2007 |
Segura MM, Garnier A, Durocher Y, Coelho H, Kamen A. Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification. Biotechnology and Bioengineering. 98: 789-99. PMID 17461423 DOI: 10.1002/Bit.21467 |
0.372 |
|
| 2007 |
Gaillet B, Gilbert R, Amziani R, Guilbault C, Gadoury C, Caron AW, Mullick A, Garnier A, Massie B. High-level recombinant protein production in CHO cells using an adenoviral vector and the cumate gene-switch. Biotechnology Progress. 23: 200-9. PMID 17269689 DOI: 10.1021/Bp060187J |
0.399 |
|
| 2007 |
Segura MM, Kamen A, Lavoie MC, Garnier A. Exploiting heparin-binding properties of MoMLV-based retroviral vectors for affinity chromatography. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 846: 124-31. PMID 16971193 DOI: 10.1016/J.Jchromb.2006.08.032 |
0.315 |
|
| 2006 |
Ghani K, Garnier A, Coelho H, Transfiguracion J, Trudel P, Kamen A. Retroviral vector production using suspension-adapted 293GPG cells in a 3L acoustic filter-based perfusion bioreactor. Biotechnology and Bioengineering. 95: 653-60. PMID 16947907 DOI: 10.1002/Bit.20947 |
0.403 |
|
| 2006 |
Segura MM, Kamen A, Garnier A. Downstream processing of oncoretroviral and lentiviral gene therapy vectors. Biotechnology Advances. 24: 321-37. PMID 16448798 DOI: 10.1016/J.Biotechadv.2005.12.001 |
0.32 |
|
| 2006 |
Segura MM, Garnier A, Kamen A. Purification and characterization of retrovirus vector particles by rate zonal ultracentrifugation. Journal of Virological Methods. 133: 82-91. PMID 16325928 DOI: 10.1016/J.Jviromet.2005.10.030 |
0.321 |
|
| 2005 |
Segura MM, Kamen A, Trudel P, Garnier A. A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatography. Biotechnology and Bioengineering. 90: 391-404. PMID 15812800 DOI: 10.1002/Bit.20301 |
0.329 |
|
| 2004 |
Cortin V, Thibault J, Jacob D, Garnier A. High-titer adenovirus vector production in 293S cell perfusion culture. Biotechnology Progress. 20: 858-63. PMID 15176892 DOI: 10.1021/Bp034237L |
0.386 |
|
| 2004 |
Quenneville SP, Ducharme M, Rousseau J, Garnier A, Tremblay JP. 537. Further characterisation of myo-neurospheres Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.663 |
0.308 |
|
| 2003 |
Jardon M, Garnier A. PH, pCO2, and temperature effect on R-adenovirus production. Biotechnology Progress. 19: 202-8. PMID 12573026 DOI: 10.1021/Bp025585A |
0.335 |
|
| 2001 |
Boudreault P, Tremblay JP, Pépin MF, Garnier A. Scale-up of a myoblast culture process. Journal of Biotechnology. 91: 63-74. PMID 11522363 DOI: 10.1016/S0168-1656(01)00291-7 |
0.351 |
|
| 2001 |
El Zoeiby A, Sanschagrin F, Havugimana PC, Garnier A, Levesque RC. In vitro reconstruction of the biosynthetic pathway of peptidoglycan cytoplasmic precursor in Pseudomonas aeruginosa. Fems Microbiology Letters. 201: 229-35. PMID 11470366 DOI: 10.1111/J.1574-6968.2001.Tb10761.X |
0.312 |
|
| 2001 |
Garnier A, Gilbert P, Kamen A. Modeling of the Diffusion/ Adsorption Process of 293S Cells Infected by Recombinant Adenoviruses Ifac Proceedings Volumes. 34: 367-372. DOI: 10.1016/S1474-6670(17)34247-7 |
0.312 |
|
| 2000 |
Gilbert PA, Garnier A, Jacob D, Kamen A. On-line measurement of green fluorescent protein (GFP) fluorescence for the monitoring of recombinant adenovirus production Biotechnology Letters. 22: 561-567. DOI: 10.1023/A:1005672410905 |
0.502 |
|
| 1994 |
Garnier A, Côté J, Nadeau I, Kamen A, Massie B. Scale-up of the adenovirus expression system for the production of recombinant protein in human 293S cells Cytotechnology. 15: 145-155. PMID 7765926 DOI: 10.1007/Bf00762389 |
0.408 |
|
| Show low-probability matches. |